T. Rowe Price Sees Price Grow

Jacob Harper  |

Asset manager T. Rowe Price (TROW) was one of the biggest gainers in early Jan. 28 action, with shares gapping as much as 6 percent following the release of the company’s Q4 2013 earnings report. The report was positive, spurred on by increased assets and favorable macro conditions.

The report indicated that the Financials play had increased earnings by 24 percent sending shares sharply up. While T. Rowe Price has a long history of consistently turning a profit, this most recent report showed their most significant growth increase in over two years.

T. Rowe Price certainly benefited from the bull run the Financial sector has been on, with the sector as a whole experiencing a major resurgence in 2013. Over three-quarters of the company’s assets are in equities, so the company more or less moves in accordance with the market, if not beating it slightly. T. Rowe Price has doubled in value over since the 2008 recession, and currently sits at an all time high.

For their fourth quarter 2013 earnings report, T. Rowe Price reported a net gain of $284.4 million, or $1.06 per share, versus the net profit of $229.9 million, or $0.88 per share, from the same period a year ago. Revenue for the quarter was $929.8 million, as compared to $787.3 million from the same quarter the previous year. Analysts were expecting a profit of $1.02 per share on revenues of $917 million.

For the 2013 fiscal year, T. Rowe Price reported revenues of $3.5 billion, a 16.7 percent increase from 2012. The company has never lost money since going public in 1986.

T. Rowe Price popped to an all-time high in early action before settling slightly. The company’s shares were at $81.04 a share at midday, representing a spike of 5.92 percent on the day.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
TROW T. Rowe Price Group Inc. 105.90 -0.19 -0.18 1,319,331 Trade
PRTT Protect Pharmaceutical 1.05 0.00 0.00 0



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Joseph Weinberg CEO PayCase, Chairman Shyft

Matt Bird sits down with Joseph Weinberg CEO PayCase, Chairman Shyft at the World Economic Forum at Davos 2019